Zydus Lifesciences stock faces resistance at ₹920 and ₹940, with a downtrend likely to continue despite recent recovery.

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

The Nifty Pharma index closed on a negative note on Friday. Shares of Mankind Pharma Ltd.(up 1.84 per cent), Gland Pharma Ltd ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

AM(IST)on Thursday in an upbeat market. Gland Pharma Ltd.(up 3.66 per cent), Zydus Lifesciences Ltd.(up 3.17 per cent), ...

Benchmark BSE Sensex surged by 740 points while Nifty snapped its 10-day losing streak on Wednesday (March 5) following value ...

Stocks including TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc, R Systems, Zaggle Prepaid, IRFC and ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Stocks like Wipro, Walchandnagar Industries, Hindustan Zinc, R Systems International, Kirloskar Industries, Zaggle Prepaid ...

The NSE Nifty 50 ended 254.65 points or 1.15% higher at 22,337.30, while the BSE Sensex closed 740.30 points or 1.01% up at ...